A California-based biotech company is finding early success on Tuesday after the company announced positive preliminary data of Vebreltinib in patients with non-CNS met fusion...

To read the full story on AllPennyStocks.com, click here.

Apollomics (NASDAQ:APLM)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Apollomics Charts.
Apollomics (NASDAQ:APLM)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Apollomics Charts.